查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1546204

質子治療的全球市場

Proton Therapy
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球質子治療市場預計將達到 15 億美元

2023年全球質子治療市場估計為6.146億美元，預計到2030年將達到15億美元，2023年至2030年複合年成長率為13.5%。加速器是本報告分析的細分市場之一，預計複合年成長率為 13.7%，到分析期結束時將達到 8.436 億美元。分析期間，光束傳輸系統領域的複合年成長率預計為 14.2%。

美國市場預估為1.656億美元，中國預期複合年成長率為12.5%

預計 2023 年美國質子治療市場規模將達到 1.656 億美元。中國作為全球第二大經濟體，預計2030年市場規模將達2.238億美元，推動2023-2030年分析期間複合年成長率為12.5%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 12.0% 和 11.2%。在歐洲，德國的複合年成長率預計約為 9.5%。

全球質子治療市場 - 主要趨勢和促進因素總結

不斷成長的質子治療市場以高精度標靶化癌症

質子治療是最先進的放射線治療，透過提供高度精確和有效的腫瘤標靶選擇，正在改變癌症治療的面貌。與會損害周圍健康組織的傳統 X光輻射不同，質子療法使用帶電粒子（質子）將其最大能量直接傳遞到腫瘤部位，從而最大限度地減少對鄰近健康組織的損害。這種精確性使得質子療法在治療大腦、脊椎和眼睛等關鍵結構附近的腫瘤時特別有用，而傳統的放射治療在這些部位可能會產生嚴重的副作用。隨著人們越來越重視癌症治療的精準性和個人化，質子治療被認為是許多患者的更好選擇，尤其是兒童和病情複雜的患者。

科技進步如何增強質子治療？

技術進步在擴大和改進質子治療方面發揮著至關重要的作用。影像技術的創新，例如基於 MRI 和 CT 的治療計劃，顯著提高了質子束照射的準確性，使臨床醫生能夠更好地可視化腫瘤並精確地計劃治療。筆射束掃描 (PBS) 技術的發展進一步提高了質子治療的精確度，能夠提供與腫瘤精確形狀相符的高度聚焦束，從而減少對周圍健康組織的劑量。此外，加速器技術的進步減少了治療設施的規模和成本，使質子治療更容易實現。這些技術進步使質子治療成為世界各地癌症治療中心更可行、更有吸引力的選擇。

質子束治療的擴展應用有哪些？

隨著臨床證據支持質子束療法治療多種癌症的有效性，質子束療法的應用正在擴大。質子療法傳統上用於治療兒童癌症和關鍵結構附近的腫瘤，但現在它被用於乳腺癌、肺癌和胃腸道癌症，在這些癌症中，盡量減少對周圍組織的輻射照射非常重要。癌症。質子束療法有可能減少長期副作用並提高癌症倖存者的生活品質，使其可用於頭部和頸部，因為唾液腺和聲帶等重要器官可能受到嚴重損傷。此外，正在進行的研究正在調查如何將其與免疫療法和化療等其他治療方法結合使用，以提高整體治療效果。這些擴展的應用正在擴大質子束治療在癌症治療中的範圍。

市場成長的主要驅動力是什麼？

質子治療市場的成長受到多種因素的推動。全球癌症發生率的增加是一個主要促進因素，因為對先進、準確和有效的治療方案的需求不斷增加。成像、光束傳輸和加速器設計方面的技術進步極大地提高了質子治療的可及性和有效性，使其成為治療中心更有吸引力的選擇。質子療法治療的癌症範圍不斷擴大，以及越來越多的臨床證據支持其益處，也推動了質子療法的採用。此外，對個人化醫療和精準醫療的日益關注正在推動質子治療的使用，特別是在傳統放射治療可能導致嚴重副作用的情況下。隨著全球醫療保健界繼續優先考慮以患者為中心的護理，對質子治療的需求預計將顯著成長。

調查企業範例（共43例）

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP14268

Global Proton Therapy Market to Reach US$1.5 Billion by 2030

The global market for Proton Therapy estimated at US$614.6 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 13.5% over the analysis period 2023-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. Growth in the Beam Delivery Systems segment is estimated at 14.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$165.6 Million While China is Forecast to Grow at 12.5% CAGR

The Proton Therapy market in the U.S. is estimated at US$165.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$223.8 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Global Proton Therapy Market - Key Trends and Drivers Summarized

Targeting Cancer with Precision: The Growing Market for Proton Therapy

Proton therapy is a cutting-edge form of radiation therapy that is transforming the way cancer is treated, offering a highly precise and effective option for targeting tumors. Unlike conventional X-ray radiation, which can damage surrounding healthy tissues, proton therapy uses charged particles (protons) that deliver their maximum energy directly to the tumor site, minimizing collateral damage to adjacent healthy cells. This precision makes proton therapy particularly valuable in treating tumors located near critical structures, such as the brain, spine, and eyes, where conventional radiation could cause significant side effects. As cancer treatment becomes increasingly focused on precision and personalized care, proton therapy is gaining recognition as a superior option for many patients, especially children and those with complex cases.

How Are Technological Advancements Enhancing Proton Therapy?

Technological advancements have played a pivotal role in the expansion and improvement of proton therapy. Innovations in imaging technologies, such as MRI and CT-based planning, have significantly enhanced the accuracy of proton beam delivery, allowing clinicians to better visualize tumors and plan treatments with pinpoint precision. The development of pencil beam scanning (PBS) technology has further improved the precision of proton therapy by enabling the delivery of highly focused beams that can conform to the exact shape of the tumor, reducing the dose to surrounding healthy tissues. Additionally, advancements in accelerator technology have made proton therapy more accessible by reducing the size and cost of treatment facilities. These technological improvements are making proton therapy a more viable and attractive option for cancer treatment centers around the world.

What Are the Expanding Applications of Proton Therapy?

The applications of proton therapy are expanding as more clinical evidence supports its efficacy in treating a wide range of cancers. While traditionally used for pediatric cancers and tumors near critical structures, proton therapy is now being explored for use in treating breast, lung, and gastrointestinal cancers, where minimizing radiation exposure to surrounding tissues is crucial. The potential for proton therapy to reduce long-term side effects and improve the quality of life for cancer survivors is also driving its adoption in the treatment of head and neck cancers, where traditional radiation can cause significant damage to critical organs such as the salivary glands and vocal cords. Additionally, ongoing research is investigating the use of proton therapy in combination with other treatments, such as immunotherapy and chemotherapy, to enhance overall treatment outcomes. These expanding applications are broadening the scope of proton therapy in cancer care.

What Are the Key Growth Drivers in the Market?

The growth in the proton therapy market is driven by several factors. The increasing incidence of cancer worldwide is a major driver, as the demand for advanced, precise, and effective treatment options continues to rise. Technological advancements in imaging, beam delivery, and accelerator design have significantly improved the accessibility and efficacy of proton therapy, making it a more attractive option for treatment centers. The expanding range of cancers that can be treated with proton therapy, coupled with the growing body of clinical evidence supporting its benefits, is also driving adoption. Additionally, the increasing focus on personalized and precision medicine is encouraging the use of proton therapy, particularly in cases where traditional radiation could cause significant side effects. As the global healthcare community continues to prioritize patient-centered care, the demand for proton therapy is expected to grow substantially.

Select Competitors (Total 43 Featured) -

  • Advanced Oncotherapy Plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Koninklijke Philips NV
  • Mevion Medical Systems, Inc.
  • Mitsubishi Corporation
  • Optivus Proton Therapy, Inc.
  • Protom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Proton Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Propels Market Growth
    • Increasing Adoption of Advanced Radiation Therapies Expands Addressable Market Opportunity
    • Technological Advancements in Proton Therapy Systems Strengthen Market Position
    • Growing Focus on Precision Medicine Drives Adoption of Proton Therapy
    • Surge in Demand for Non-Invasive Cancer Treatments Generates New Opportunities
    • Development of Compact and Affordable Proton Therapy Systems Sustains Market Growth
    • Expanding Applications in Pediatric Oncology Throws Spotlight on Market Potential
    • Growth in Global Healthcare Infrastructure Spurs Demand for Proton Therapy
    • Rising Awareness of Proton Therapy's Advantages Over Traditional Radiation Propels Market Expansion
    • Surge in Demand from Emerging Markets Expands Market Horizons
    • Innovations in Image-Guided Proton Therapy Generate New Market Opportunities
    • Increasing Reimbursement Support for Proton Therapy Treatments Accelerates Market Growth
    • Rising Number of Proton Therapy Centers Worldwide Throws Spotlight on Market Dynamics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Proton Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Proton Therapy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Accelerators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Accelerators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Beam Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Beam Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Beam Transport Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Beam Transport Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CNS Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for CNS Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Head & Neck Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Head & Neck Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Proton Therapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Proton Therapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Proton Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Proton Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Proton Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Proton Therapy by Product - Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Proton Therapy by Product - Percentage Breakdown of Value Sales for Accelerators, Beam Delivery Systems, Beam Transport Systems and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Proton Therapy by Indication - CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Proton Therapy by Indication - Percentage Breakdown of Value Sales for CNS Cancer, Prostate Cancer, Head & Neck Cancer, Breast Cancer and Other Indications for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Proton Therapy by End-Use - Hospitals, Proton Therapy Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Proton Therapy by End-Use - Percentage Breakdown of Value Sales for Hospitals, Proton Therapy Centers and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION